Mineralys Therapeutics, Inc. MLYS Deferred Tax Assets - Tax Credit Carryforwards
Deferred Tax Assets - Tax Credit Carryforwards at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:TaxCreditCarryforwardAmount.
The official record: Mineralys Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s deferred tax assets - tax credit carryforwards.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s deferred tax assets - tax credit carryforwards?
- Mineralys Therapeutics, Inc. (MLYS) reported deferred tax assets - tax credit carryforwards of $21.6M in Q4 2025.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s deferred tax assets - tax credit carryforwards?
- Over 2 years (2023 to 2025), Mineralys Therapeutics, Inc.'s deferred tax assets - tax credit carryforwards has grown at a 94.7% compound annual growth rate (CAGR), from $5.7M to $21.6M.